SCHEMBL23315229

SCHEMBL23315229

O=C(C(OC1CCCC1)c1ccccc1)N1CCc2c(ccc(F)c2OCc2ccccc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 8/20 0.43
AGTR1 P30556 2/20 0.39
HCRTR2 O43614 1/20 0.36
ACACB O00763 1/20 0.36
TMEM97 Q5BJF2 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
CHRM4 P08173 1/20 0.36
HTR1A P08908 1/20 0.36
CHRM5 P08912 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
HRH2 P25021 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
ADRA1B P35368 1/20 0.36
DRD3 P35462 1/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23315251 0.90 AGTR2 (0.51) AGTR2AGTR1HCRTR2ACACBTMEM97
SCHEMBL23315455 0.90 AGTR2 (0.43) AGTR2AGTR1HCRTR2ACACBTMEM97
SCHEMBL23315257 0.90 AGTR2 (0.43) AGTR2AGTR1HCRTR2ACACBTMEM97
SCHEMBL23315338 0.88 AGTR2 (0.57) AGTR2AGTR1HCRTR2ACACB
SCHEMBL23315202 0.88 AGTR2 (0.42) AGTR2AGTR1HCRTR2ACACBTMEM97
SCHEMBL23315327 0.88 AGTR2 (0.42) AGTR2AGTR1HCRTR2ACACBTMEM97
SCHEMBL23315290 0.87 AGTR2 (0.57) AGTR2AGTR1HCRTR2ACACB
SCHEMBL23315639 0.86 AGTR2 (0.52) AGTR2AGTR1HCRTR2ACACBPTGDR2
SCHEMBL23315299 0.86 AGTR2 (0.52) AGTR2AGTR1HCRTR2ACACB
SCHEMBL21881363 0.83 AGTR2 (0.60) AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3620454-B1 CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-05-05 EP disclosed